Our flow cytometry analyses showed that NSCLC cells treated with NMP expressed similar mean GFP-LC3 fluorescence intensities to Baf treatment group (Figure 7C), suggesting that NMP inhibited late autophagic flux. Here, MAP1LC3A is linked to non-small cell lung carcinoma.